三博脑科收盘上涨1.61%，滚动市盈率132.55倍，总市值111.48亿元

Group 1 - The core viewpoint of the article highlights the financial performance and market position of Sanbo Brain Science, indicating a significant increase in revenue but a decline in net profit [1] - As of December 12, Sanbo Brain Science's stock closed at 54.12 yuan, with a rolling PE ratio of 132.55 times and a total market capitalization of 11.148 billion yuan [1] - The company ranks 38th in the medical services industry, which has an average PE ratio of 49.50 times and a median of 61.79 times [1] Group 2 - For the third quarter of 2025, Sanbo Brain Science reported a revenue of 1.273 billion yuan, representing a year-on-year increase of 20.26% [1] - The net profit for the same period was 83.6282 million yuan, showing a year-on-year decrease of 20.01%, with a sales gross margin of 24.87% [1] - A total of 8 institutions held shares in Sanbo Brain Science, with a combined holding of 41.1976 million shares valued at 2.408 billion yuan [1]